mFOLFOX6+bevacizumab + PD-1 monoclonal antibody in locally advanced MSS CRC (BASKETII): A prospective, single-arm, open-label, phase II study

被引：0
|
作者：
Huang, J. [1 ]
He, W. [2 ]
Zhao, Y. [3 ]
He, F. [4 ]
Liu, Z. [5 ]
Pei, F. [6 ]
Yao, Q. [7 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Colorectal Surg, Guangzhou, Peoples R China
[2] Jinan Univ, Shenzhen Peoples Hosp, Oncol Dept, Shenzhen, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 6, Radiotherapy, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 6, Coloproctol, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
10.1016/j.annonc.2024.10.096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
74MO
引用
收藏
页码：S1433 / S1433
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of cadonilimab combined with FLOT regimen as a neoadjuvant therapy for locally advanced gastric/gastroesophageal junction adenocarcinoma: A prospective, multicenter, open-label, single-arm phase II study
    Long, B.
    Zhou, H.
    Wei, D.
    Yang, T.
    Chai, N.
    Yu, Z.
    Yang, H.
    Guan, X.
    Zhang, W.
    Chen, S.
    Zhou, L.
    Jiang, X.
    Shi, W.
    Huang, Z.
    Zhu, J.
    Luo, C.
    Mao, J.
    Dong, C.
    Jiang, Z.
    Zhao, X.
    Zhao, D.
    Jiao, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S70 - S71
  • [32] A multicenter, open-label, single-arm, phase IV study evaluating the safety of biosimilar bevacizumab in patients with solid tumors
    Narayanan, P.
    Upveja, K. H.
    Deodhar, S.
    Kapur, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S1613 - S1613
  • [33] Anlotinib in patients with recurrent advanced cervical cancer: A prospective single-arm, open-label, phase. trial.
    Wu, Xiaohua
    Zhu, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Camrelizumab monotherapy or in combination with apatinib for PD-L1-positive advanced pulmonary sarcomatoid carcinoma: A multicenter, open-label, single-arm, phase II study.
    Zhao, Mingfang
    Han, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.
    Wei, Wei
    Ban, Xiaohua
    Yang, Fan
    Huang, Yongwen
    Li, Jibin
    Qiu, Ya
    Cheng, Xiaqin
    Li, Jundong
    Zheng, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study
    Cheng, Yu
    Teng, Zan
    Zhang, Yanqiao
    Jin, Bo
    Zheng, Zhendong
    Man, Li
    Wang, Zhenghua
    Teng, Yuee
    Yu, Ping
    Shi, Jing
    Luo, Ying
    Wang, Ying
    Zhang, Jingdong
    Zhang, Huijuan
    Liu, Jiwei
    Chen, Hao
    Xiao, Jiawen
    Zhao, Lei
    Zhang, Lingyun
    Jiang, Yu
    Chen, Ying
    Zhang, Jian
    Wang, Chang
    Liu, Sa
    Qu, Jinglei
    Qu, Xiujuan
    Liu, Yunpeng
    BMC CANCER, 2024, 24 (01)
  • [37] Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
    Migden, Michael R.
    Khushalani, Nikhil I.
    Chang, Anne Lynn S.
    Lewis, Karl D.
    Schmults, Chrysalyne D.
    Hernandez-Aya, Leonel
    Meier, Friedegund
    Schadendorf, Dirk
    Guminski, Alexander
    Hauschild, Axel
    Wong, Deborah J.
    Daniels, Gregory A.
    Berking, Carola
    Jankovic, Vladimir
    Stankevich, Elizabeth
    Booth, Jocelyn
    Li, Siyu
    Weinreich, David M.
    Yancopoulos, George D.
    Lowy, Israel
    Fury, Matthew G.
    Rischin, Danny
    LANCET ONCOLOGY, 2020, 21 (02): : 294 - 305
  • [38] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Ito, Shuichi
    Nishiyama, Yuya
    Sugiura, Kenkichi
    Enya, Kazuaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (04) : 350 - 358
  • [39] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [40] Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
    Cao, Yanshuo
    Lu, Ming
    Sun, Yu
    Gong, Jifang
    Li, Jie
    Lu, Zhihao
    Li, Jian
    Zhang, Xiaotian
    Li, Yan
    Peng, Zhi
    Zhou, Jun
    Wang, Xicheng
    Shen, Lin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 779 - 789
12345